Ranked #1
Next-gen immunotherapies for cancer, Andrew Scharenberg, Co-founder & CEO, Umoja Biopharma
Next-gen immunotherapies for cancer, Andrew Scharenberg, Co-founder & CEO, Umoja Biopharma
Synopsis: Andrew Scharenberg is the Co-founder and CEO of Umoja Biopharma, a company pioneering the future of immunother... Read more
9 Aug 2023
•
32mins
Ranked #2
Transforming medicine through non-viral gene therapy, Theresa Heah, CEO, Intergalactic Tx
Transforming medicine through non-viral gene therapy, Theresa Heah, CEO, Intergalactic Tx
Synopsis: Theresa Heah, M.D., is the CEO of Intergalactic Therapeutics. Intergalactic is overcoming the limitations of v... Read more
2 Aug 2023
•
19mins
Similar Podcasts
Ranked #3
Transforming diseased cells into coordinators of cure, Volker Herrmann, President & CEO, Sonata Tx
Transforming diseased cells into coordinators of cure, Volker Herrmann, President & CEO, Sonata Tx
Synopsis: Volker Herrmann is the President and CEO of Sonata Therapeutics, a Flagship Pioneering company revolutionizing... Read more
26 Jul 2023
•
34mins
Ranked #4
Breaking barriers in rare genetic mitochondrial diseases, Greg Flesher, Pres. & CEO, Reneo
Breaking barriers in rare genetic mitochondrial diseases, Greg Flesher, Pres. & CEO, Reneo
Synopsis: Greg Flesher is the President and CEO of Reneo Pharmaceuticals, a clinical-stage pharmaceutical company focuse... Read more
19 Jul 2023
•
27mins
Ranked #5
Correcting abnormal gene expression in oncology, Adrian Gottschalk, Pres. & CEO, Foghorn Tx
Correcting abnormal gene expression in oncology, Adrian Gottschalk, Pres. & CEO, Foghorn Tx
Synopsis: Adrian Gottschalk is the president and CEO of Foghorn Therapeutics, a clinical-stage biotechnology company pio... Read more
12 Jul 2023
•
31mins
Ranked #6
Epigenetic therapies for organ injury & chronic liver diseases, Jim Brown, Pres. & CEO, DURECT
Epigenetic therapies for organ injury & chronic liver diseases, Jim Brown, Pres. & CEO, DURECT
Synopsis: Jim Brown is the President and CEO of DURECT Corporation, a biopharmaceutical company committed to transformin... Read more
5 Jul 2023
•
29mins
Ranked #7
New vision for preventing & curing age-related diseases, James Peyer, Founder & CEO, Cambrian Bio
New vision for preventing & curing age-related diseases, James Peyer, Founder & CEO, Cambrian Bio
Synopsis: James Peyer, Ph.D., is the Founder and CEO of Cambrian Bio, a clinical-stage drug-development company focused ... Read more
28 Jun 2023
•
29mins
Ranked #8
Revolutionizing T-cells for solid tumor cell therapies, Gary Lee, CSO, Lyell Immunopharma
Revolutionizing T-cells for solid tumor cell therapies, Gary Lee, CSO, Lyell Immunopharma
Synopsis: Gary Lee, Ph.D. is the CSO of Lyell Immunopharma, a T-cell reprogramming company dedicated to developing cell ... Read more
21 Jun 2023
•
28mins
Ranked #9
Mobilizing the immune system to combat disease, Liang Schweizer, Founder & CEO, HiFiBiO Tx
Mobilizing the immune system to combat disease, Liang Schweizer, Founder & CEO, HiFiBiO Tx
Synopsis: Liang Schweizer, Ph.D. is the Founder and CEO of HiFiBiO Therapeutics, a clinical-stage global biotech company... Read more
14 Jun 2023
•
30mins
Ranked #10
BIO Special: New vision for immunotherapy, Detlev Biniszkiewicz, Founder & CEO, NextPoint Tx
BIO Special: New vision for immunotherapy, Detlev Biniszkiewicz, Founder & CEO, NextPoint Tx
Synopsis: Detlev Biniszkiewicz is the Founder and CEO of NextPoint Therapeutics, a company advancing the field of immuno... Read more
7 Jun 2023
•
34mins